Berger MF, Garraway LA. Applications of genomics in melanoma oncogene discovery. Hematol Oncol Clin North Am. 2009;23(3):397-414, vii. doi:10.1016/j.hoc.2009.03.005
Tabebordbar M, Zhu K, Cheng JKW, et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science. 2016;351(6271):407-11. doi:10.1126/science.aad5177
Zhang F. CRISPR-Cas9: Prospects and Challenges. Hum Gene Ther. 2015;26(7):409-10. doi:10.1089/hum.2015.29002.fzh
Lander ES. Brave New Genome. N Engl J Med. 2015;373(1):5-8. doi:10.1056/NEJMp1506446
Sankaran VG, Weiss MJ. Anemia: progress in molecular mechanisms and therapies. Nat Med. 2015;21(3):221-30. doi:10.1038/nm.3814
Cox DBT, Platt RJ, Zhang F. Therapeutic genome editing: prospects and challenges. Nat Med. 2015;21(2):121-31. doi:10.1038/nm.3793
Suzuki T, Arumugam P, Sakagami T, et al. Pulmonary macrophage transplantation therapy. Nature. 2014;514(7523):450-4. doi:10.1038/nature13807
Edwards MD, Symbor-Nagrabska A, Dollard L, Gifford DK, Fink GR. Interactions between chromosomal and nonchromosomal elements reveal missing heritability. Proc Natl Acad Sci U S A. 2014;111(21):7719-22. doi:10.1073/pnas.1407126111
Greulich H, Chen TH, Feng W, et al. Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants. PLoS Med. 2005;2(11):e313. doi:10.1371/journal.pmed.0020313